Literature DB >> 2504713

Biochemical analysis of CRM 66. A nonfunctional Pseudomonas aeruginosa exotoxin A.

D R Galloway1, R C Hedstrom, J L McGowan, S P Kessler, D J Wozniak.   

Abstract

Pseudomonas aeruginosa exotoxin A (ETA) is an ADP-ribosyltransferase which inactivates protein synthesis by covalently attaching the ADP-ribose portion of NAD+ onto eucaryotic elongation factor 2 (EF-2). A direct biochemical comparison has been made between ETA and a nonenzymatically active mutant toxin (CRM 66) using highly purified preparations of each protein. The loss of ADP-ribosyltransferase activity and subsequent cytotoxicity have been correlated with the presence of a tyrosine residue in place of a histidine at position 426 in CRM 66. In the native conformation, CRM 66 demonstrated a limited ability (by a factor or at least 100,000) to modify EF-2 covalently and lacked in vitro and in vivo cytotoxicity, yet CRM 66 appeared to be normal with respect to NAD+ binding. Upon activation with urea and dithiothreitol, CRM 66 lost ADP-ribosyltransferase activity entirely yet CRM 66 retained the ability to bind NAD+. Replacement of Tyr-426 with histidine in CRM 66 completely restored cytotoxicity and ADP-ribosyltransferase activity. These results support previous findings from this laboratory (Wozniak, D. J., Hsu, L.-Y., and Galloway, D. R. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 8880-8884) which suggest that the His-426 residue of ETA is not involved in NAD+ binding but appears to be associated with the interaction between ETA and EF-2.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2504713

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.486


  3 in total

1.  Structure-function analysis of exotoxin A proteins with mutations at histidine 426.

Authors:  M J Wick; J M Cook; B H Iglewski
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.609

2.  Construction and use of a nontoxigenic strain of Pseudomonas aeruginosa for the production of recombinant exotoxin A.

Authors:  D J Wozniak; X Y Han; D R Galloway
Journal:  Appl Environ Microbiol       Date:  1995-05       Impact factor: 5.005

3.  In vivo production of exotoxin A and its role in endogenous Pseudomonas aeruginosa septicemia in mice.

Authors:  Y Hirakata; N Furuya; K Tateda; M Kaku; K Yamaguchi
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.609

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.